Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Plasma in Cancer Treatment"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 November 2019).
Tel. +32-3-265.23.77; Fax: +32-3-265.23.43
Interests: plasma; plasma chemistry; plasma oncology; plasma medicine; plasma catalysis; computer modeling; plasma cancer immunotherapy
Special Issues and Collections in MDPI journals
Special Issue in Cancers: Select Papers from 7th International Workshop on Plasma for Cancer Treatment – IWPCT 2020
Tel. +32-3-265.92.64; Fax: +32-3-265.23.43
Interests: plasma; plasma oncology; plasma medicine; 3-dimensional in vitro models; cell biology, oxidative stress
In the last decade, research on cold atmospheric plasma (CAP) has significantly advanced our understanding of the effect of CAP on cancer cells and their potential for cancer treatment. One of the most important findings is the realization that CAP can modulate and activate multiple signaling pathways in cancer cells that contribute to their elimination. This regulatory effect is mainly mediated by the rich cocktail of reactive oxygen and nitrogen species (RONS) created by plasma. This has been demonstrated for different cancer cell lines and enabled the realization of the first clinical trials with promising results. In addition, plasma could be combined with other treatments -such as immunotherapy- to boost its anticancer activity. The addition of new research tools to study the response of cancer cells to CAP -such as 3-dimensional in vitro, in ovo and in vivo models and in silico approaches- as well as the use of -OMICS technologies which facilitate the high-throughput study of the genome, proteome, transcriptome and metabolome could aid to unravel the underlying mechanisms of CAP in cancer treatment.
In order to progress towards a widespread clinical application of CAP, an integrated study of the multidimensional effect of CAP in cancer treatment is essential. In this Special Issue, we will publish reviews and original research papers that provide new insights into the mechanisms of cold atmospheric plasma in cancer treatment, based on in vitro and in vivo experiments, clinical studies, as well as by computer modeling.
Prof. Dr. Annemie Bogaerts
Dr. Angela Privat-Maldonado
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Mechanistic studies of plasma effects on cancer cells
- Selectivity studies (cancer vs normal cells)
- In vitro (2D and 3D cell cultures), in ovo, in vivo studies
- Combination with immunotherapy or other therapies
- Cell signaling pathways
- Role of RONS in cancer treatment
- Clinical trials
- Tumor microenvironment